Published in Aliment Pharmacol Ther on January 06, 2014
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers. Gastroenterol Res Pract (2015) 0.91
Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther (2015) 0.87
Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation. Am J Gastroenterol (2016) 0.78
Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls. Parasit Vectors (2015) 0.77
A novel biomarker panel for irritable bowel syndrome and the application in the general population. Sci Rep (2016) 0.76
Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome? BMC Gastroenterol (2016) 0.76
Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past. Clin Transl Gastroenterol (2015) 0.76
Serum biomarkers for irritable bowel syndrome. Clujul Med (2015) 0.75
Diagnosing irritable bowel syndrome with a combination of biomarkers and "psychomarkers". Gastroenterology (2014) 0.75
Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil (2016) 0.75
Evolution of the Diagnosis of Functional Gut Disorders: Is an Objective Positive Diagnostic Approach Within Reach? Clin Transl Gastroenterol (2015) 0.75
Lysozyme association with circulating RNA, extracellular vesicles, and chronic stress. BBA Clin (2016) 0.75
The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. J Neurogastroenterol Motil (2017) 0.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med (1994) 5.14
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62
Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA (1991) 4.57
Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A (1996) 4.11
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology (1994) 3.89
The sexual and reproductive behavior of American women, 1982-1988. Fam Plann Perspect (1991) 3.84
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
A study of twelve Southern California communities with differing levels and types of air pollution. I. Prevalence of respiratory morbidity. Am J Respir Crit Care Med (1999) 3.71
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer. Oncogene (2011) 3.59
Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India (2007) 3.52
Who should fill the care gap in HIV disease? Lancet (1993) 3.26
A study of twelve Southern California communities with differing levels and types of air pollution. II. Effects on pulmonary function. Am J Respir Crit Care Med (1999) 3.18
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use. Fam Plann Perspect (2002) 3.12
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
The need for prenatal care in the United States: evidence from the 1980 National Natality Survey. Fam Plann Perspect (1987) 2.93
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82
Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer (1974) 2.80
Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73
Macrophage activation syndrome: experience from a tertiary referral centre. J Assoc Physicians India (2007) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol (1996) 2.69
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67
Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A (1974) 2.66
Timing of prenatal care in the United States: how accurate are our measurements? Health Serv Res (1987) 2.61
Pneumocystis carinii infection in patients of AIDS in India. J Assoc Physicians India (1993) 2.57
Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet (1992) 2.55
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled study. J Postgrad Med (2006) 2.43
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38
Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
Bacteriological study of Indian cheese (paneer) sold in Chandigarh. Indian J Med Microbiol (2007) 2.34
Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32
Do mussels take wooden steps to deep-sea vents? Nature (2000) 2.32
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
Development and mapping of microsatellite (SSR) markers in wheat. Theor Appl Genet (2005) 2.27
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM (2010) 2.27
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther (2014) 2.18
Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2014) 2.17
Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis (1987) 2.16
Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis (1984) 2.15
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD. Eur Respir J (2009) 2.10
Sexually transmitted diseases among adolescents in developed countries. Fam Plann Perspect (2000) 2.10
Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Int J Cancer (1974) 2.10
Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature (1976) 2.10
Crystalline fraction I protein: preparation in large yield. Science (1972) 2.09
The incidence of abortion worldwide. Int Fam Plann Persp (1999) 2.09
The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell (1989) 2.07
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther (2008) 2.06
The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05
Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology (1995) 2.02
Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. Proc Natl Acad Sci U S A (1994) 2.02
DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (1973) 2.02
Cystic lymphangioma in children: report of 32 cases including lesions atrrare sites. Surgery (1971) 2.02
Instructing subjects to make a voluntary response reveals the presence of two components to the audio-vocal reflex. Exp Brain Res (2000) 2.01
The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01
Air pollution and daily hospital admissions in metropolitan Los Angeles. Environ Health Perspect (2000) 1.99
Day-to-day particulate exposures and health changes in Los Angeles area residents with severe lung disease. J Air Waste Manag Assoc (1999) 1.99
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
The general practitioner and human immunodeficiency virus infection: an insight into patients' attitudes. J R Coll Gen Pract (1989) 1.96
Changing emphases in sexuality education in U.S. public secondary schools, 1988-1999. Fam Plann Perspect (2001) 1.90
Multiplex PCR assay for simultaneous detection and differentiation of Mycobacterium tuberculosis, Mycobacterium avium complexes and other Mycobacterial species directly from clinical specimens. J Appl Microbiol (2009) 1.90
Contraceptive failure in the first two years of use: differences across socioeconomic subgroups. Fam Plann Perspect (2001) 1.90
Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85
Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84
Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84
Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81
Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene (2006) 1.79
Reversible cold inactivation and heat reactivation of RuDP carboxylase activity of crystallized tobacco fraction I protein. Biochem Biophys Res Commun (1971) 1.79
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
The challenges of involving traditional healers in HIV/AIDS care. Int J STD AIDS (2006) 1.78
Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol (2007) 1.78
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal. Int J Tuberc Lung Dis (2003) 1.76
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75